This paper examines the pharmacology and clinical effects of commonly used inhalation anesthetic agents, including halothane, enflurane, desflurane, isoflurane, nitrous oxide, and sevoflurane. Beginning with the basic mechanisms by which inhaled agents produce anesthesia—particularly the role of blood-gas solubility coefficients in determining onset speed—the paper then reviews each agent individually, covering indications, contraindications, dosages, and cardiovascular and respiratory effects. The discussion highlights how differences in solubility, potency, and analgesic properties influence agent selection for specific surgical scenarios, and concludes that patient history, desired depth of sedation, and potential side effects must all guide clinical decision-making.
A variety of anesthetic techniques are available in clinical practice today for different surgical situations. A trained anesthetist decides the most appropriate method for each case and possesses the necessary skills to apply the technique of choice. Volatile anesthetic agents are commonly used and have an important safety feature: agents that enter the circulation via the lungs may leave by the same route. Thus, the concentration of anesthetic at the brain can be rapidly reduced as long as the patient is breathing adequately.
General anesthetics are used to produce unconsciousness during surgery. Unlike local anesthetics, which are used in dentistry and minor surgery, general anesthetics circulate throughout the body, resulting in a stronger action on the nervous system and a greater potential for side effects.
An agent inhaled into the lungs will enter the circulation and be carried to all tissues of the body. The concentration that reaches the brain produces the state of anesthesia. The exact mechanism of anesthesia is poorly understood, but it appears that nerve cells absorb the agent, thereby reducing their ability to conduct impulses to one another. The more soluble the agent is in blood, the longer it takes to build up an effective concentration in the brain and the slower the onset of unconsciousness. With a very soluble agent, the induction of anesthesia is therefore prolonged.
Conversely, with an agent that is relatively insoluble in blood, the blood becomes saturated quickly, the brain concentration rises rapidly, and the clinical effect is seen sooner. The degree of solubility of an agent in blood is indicated by its blood-gas solubility coefficient.
Halothane is a well-tolerated, non-irritant, potent agent that provides rapid induction, low-dose maintenance, and rapid recovery. There is a predictable, dose-related depression of respiration and cardiac function. Because halothane is a very potent agent, it is not suitable for use by untrained anesthetic staff. Its poor analgesic properties necessitate deep planes of anesthesia before surgery can be tolerated. For this reason, it is generally not suitable as a sole agent without an analgesic supplement—such as nitrous oxide, trichloroethylene, a local anesthetic block, or another analgesic—especially during spontaneous respiration. The depression of the cardiovascular system may cause bradycardia, hypotension, and a reduction in cardiac output (Desalu, Kushimo, & Odelola, 2004). The combined depressant effects on the circulation and respiration mean that supplemental oxygen should always be given during anesthesia and the early recovery phase.
Indications for halothane include almost all forms of general anesthesia. Contraindications include simultaneous administration with adrenaline—especially during spontaneous breathing—or a history of hepatitis following a previous anesthetic. Common dosages include inspired concentrations of up to 3%. A maintenance dose is 1–2% for spontaneously breathing patients and 0.5–1% during controlled ventilation (Preckel et al., 2004).
Overall, the use of halothane alone in general anesthesia is not ideal because it has no analgesic properties and high concentrations are needed to abolish reflex activity. This becomes expensive and may also be unsafe. The combination of high concentrations of halothane, oxygen, and air; elevated carbon dioxide levels from respiratory depression; and pre-existing heart disease is potentially very hazardous for the patient, especially if the pulse is not adequately monitored for arrhythmias (Gurkan, Canatay, Agacdiken, Ural, & Toker, 2003).
"Three halogenated agents compared by onset and cardiovascular impact"
"Analgesic gas and fast-acting liquid agent reviewed"
Ting, C. K., Hu, J. S., Teng, Y. H., Chang, Y. Y., Tsou, M. Y., & Tsai, S. K. (2004). Desflurane accelerates patient response during the wake-up test for scoliosis surgery. Can J Anaesth, 51(4), 393–397.
Turner, M. J., McCulloch, T. J., Kennedy, R. R., & Baker, A. B. (2004). Pharmacokinetics of sevoflurane uptake into the brain. Anaesthesia, 59(12), 1201–1206.
Vivien, B., Lecarpentier, Y., Riou, B., & Coirault, C. (2005). Halothane and isoflurane do not directly interact with cardiac cross-bridge function. Anesthesiology, 102(2), 364–370.
Zhou, Y. F., Zhao, K. M., & Chen, Q. L. (2003). Effects of enflurane on myocardial reperfusion injury during cardiac surgery with cardiopulmonary bypass. Zhejiang Da Xue Xue Bao Yi Xue Ban, 32(3), 227–230.
You’re 37% through this paper. Sign up to read the remaining 2 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.